person · Reporting owner
Wilderotter Mary Agnes
Disclosed activity across 11 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CADENCE DESIGN SYSTEMS INCCDNS · Entity 2935 | Director | February 14, 2020 | February 20, 2020 |
| COSTCO WHOLESALE CORP /NEWCOST · Entity 2803 | Director | October 22, 2025 | October 24, 2025 |
| DOCUSIGN, INC.DOCU · Entity 2242 | Director | October 01, 2026 | October 02, 2026 |
| DXC Technology CoDXC · Entity 4594 | Director | March 15, 2017 | March 17, 2017 |
| Lyft, Inc.LYFT · Entity 2493 | Director | August 28, 2023 | August 31, 2023 |
| Okta, Inc.OKTA · Entity 3154 | Director | August 13, 2025 | August 15, 2025 |
| Sana Biotechnology, Inc.SANA · Entity 4870 | Director | June 05, 2025 | June 09, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CADENCE DESIGN SYSTEMS INC
Report date February 14, 2020 · Filed February 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,235 |
Reported balance
After 2020-02-14 transaction · row 1
1 source rowRow 1 · 2020-02-14 · Grant · Acquired 2,412 · Balance 13,235 F1: Incentive stock award fully vests on February 14, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Incentive stock award fully vests on February 14, 2021.
COSTCO WHOLESALE CORP /NEW
Report date October 22, 2025 · Filed October 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,204.936 |
Reported balance
After 2025-10-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-10-22 · Grant · Acquired 286 · Balance 3,204.936 F1: Grant of Restricted Stock Units. Vests one-third on October 22, 2026, and one-third annually on October 22 for the following two years. F2: Not applicable. Grant of Restricted Stock Units. F3: On July 21, 2025, the reporting person contributed 9,752 shares of Costco common stock to a grantor retained annuity trust (GRAT-1) of which the reporting person is the sole grantor, trustee and annuity beneficiary. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT-1 | 9,752 |
Reported balance
Holding disclosure · report date 2025-10-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,752 F3: On July 21, 2025, the reporting person contributed 9,752 shares of Costco common stock to a grantor retained annuity trust (GRAT-1) of which the reporting person is the sole grantor, trustee and annuity beneficiary. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Restricted Stock Units. Vests one-third on October 22, 2026, and one-third annually on October 22 for the following two years.
F2: Not applicable. Grant of Restricted Stock Units.
F3: On July 21, 2025, the reporting person contributed 9,752 shares of Costco common stock to a grantor retained annuity trust (GRAT-1) of which the reporting person is the sole grantor, trustee and annuity beneficiary.
DOCUSIGN, INC.
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,199 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 1,000 · Balance 2,199 F1: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
DXC Technology Co
Report date March 15, 2017 · Filed March 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2017-03-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Lyft, Inc.
Report date August 28, 2023 · Filed August 31, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 55,493 |
Reported balance
After 2023-08-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-08-28 · Sale · Disposed 2,403 · Balance 55,493 F1: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). F2: This transaction was executed in multiple trades at prices ranging from $10.22 to $10.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2: This transaction was executed in multiple trades at prices ranging from $10.22 to $10.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
Okta, Inc.
Report date August 13, 2025 · Filed August 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,826 |
Reported balance
After 2025-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-13 · Grant · Acquired 5,826 · Balance 5,826 F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock. F2: 33-1/3% of the shares underlying the RSU shall vest on August 13, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock.
F2: 33-1/3% of the shares underlying the RSU shall vest on August 13, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date.
Sana Biotechnology, Inc.
Report date June 05, 2025 · Filed June 09, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.55 · Expires 2035-06-04 | Direct | 80,000 |
Reported balance
After 2025-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-05 · Grant · Acquired 80,000 · Balance 80,000 F1: The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Fortinet, Inc.
Report date June 12, 2025 · Filed June 13, 2025
Section 16 reporting ended · disclosed 2025-06-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,069 |
Reported balance
After 2025-06-12 transaction · row 1
1 source rowRow 1 · 2025-06-12 · Exercise / conversion · Acquired 1,130 · Balance 5,069 F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-06-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-12 · Exercise / conversion · Disposed 1,130 · Balance 0 F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024. F3: The RSUs will vest in substantially equal increments on each of September 30, 2024, December 31, 2024, March 31, 2025, and the earlier of (i) June 30, 2025 and (ii) the date immediately preceding the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F4: RSUs do not expire; they either vest or are canceled prior to vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on August 20, 2024.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
F3: The RSUs will vest in substantially equal increments on each of September 30, 2024, December 31, 2024, March 31, 2025, and the earlier of (i) June 30, 2025 and (ii) the date immediately preceding the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.
F4: RSUs do not expire; they either vest or are canceled prior to vest date.
Hewlett Packard Enterprise Co
Report date April 05, 2022 · Filed April 07, 2022
Section 16 reporting ended · disclosed 2022-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 95,627 |
Reported balance
After 2022-04-05 transaction · row 1
1 source rowRow 1 · 2022-04-05 · Exercise / conversion · Acquired 14,479 · Balance 95,627 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-04-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-04-05 · Exercise / conversion · Disposed 14,479 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22. F3: The number of shares in column 5 includes 333 vested RSU dividend equivalent rights and a de minimus adjustment of 0.9479 due to fractional rounding of the dividend equivalent rights at $16.26 per RSU credited to the reporting person's account on 04/05/22. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F2: As previously reported, on 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 117.5568 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 07/07/21, 115.3990 dividend equivalent rights at $14.71 per RSU credited to the reporting person's account on 10/06/21, 99.0963 dividend equivalent rights at $17.13 per RSU credited to the reporting person's account on 01/07/22.
F3: The number of shares in column 5 includes 333 vested RSU dividend equivalent rights and a de minimus adjustment of 0.9479 due to fractional rounding of the dividend equivalent rights at $16.26 per RSU credited to the reporting person's account on 04/05/22.
Juno Therapeutics, Inc.
Report date March 05, 2018 · Filed March 07, 2018
Section 16 reporting ended · disclosed 2018-03-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.72 · Expires 2024-11-03 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-05 · Disposition to issuer · Disposed 75,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.00 · Expires 2025-06-11 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.40 · Expires 2026-06-16 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.29 · Expires 2027-06-15 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-03-05 · Disposition to issuer · Disposed 12,000 · Balance 0 F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent. F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.
F2: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.
PROCTER & GAMBLE Co
Report date October 15, 2015 · Filed October 15, 2015
Section 16 reporting ended · disclosed 2015-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,624.122 |
Reported balance
Holding disclosure · report date 2015-10-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 15,624.122 F1: Total includes grant of dividend equivalents in the form of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Total includes grant of dividend equivalents in the form of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2021 Filed Dec 2, 2021 01:32 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 456 | $41.34 | $18,849.63 |
DisclosureSEC source: 0001209191-21-067382 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,028 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.92 to $41.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| November 28, 2021 Filed Nov 30, 2021 21:24 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000205 · wf-form4_163830748247075.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558 Underlying: Common Stock · 279 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 28, 2021, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| November 28, 2021 Filed Nov 30, 2021 21:24 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000205 · wf-form4_163830748247075.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:45 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 114 | $53.39 | $6,086.46 |
DisclosureSEC source: 0001209191-21-064789 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,484 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:45 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 2,746 | $52.82 | $145,034.11 |
DisclosureSEC source: 0001209191-21-064789 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,598 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $52.38 to $53.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 20:09 UTC | COSTCO WHOLESALE CORP /NEW COST · Entity 2803 | GrantCommon Stock | 561 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-061612 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,520 F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2022, and one-third annually on October 22 for the following two years. F2 · price: Not applicable. Grant of Restricted Stock Units. Read SEC document |
| August 28, 2021 Filed Aug 31, 2021 00:02 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000154 · wf-form4_163036812256831.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837 Underlying: Common Stock · 278 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 28, 2021, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| August 28, 2021 Filed Aug 31, 2021 00:02 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000154 · wf-form4_163036812256831.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2021 Filed Jun 23, 2021 00:38 UTC | Lyft, Inc. LYFT · Entity 2493 | GrantClass A Common Stock | 4,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042606 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,344 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs shall vest on each of August 20, 2021, November 20, 2021, February 20, 2022, and the earlier of May 20, 2022 or the day prior to the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. F2 · balance_after: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:40 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | GrantRestricted Stock Units · Derivative | 1,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000093 · wf-form4_162267359645670.xml · derivative · entry 3 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Underlying: Common Stock · 1,115 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 28, 2021, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:40 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000093 · wf-form4_162267359645670.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 29, 2020, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:40 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000093 · wf-form4_162267359645670.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:04 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 14,146 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-21-000074 · edgar.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,146 Underlying: Common Stock · 14,146 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/14/22 or the date of Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · price: On 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/14/22 or the date of Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.exercise_date: On 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/14/22 or the date of Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.expiration_date: On 05/14/21, the reporting person was granted 14,146 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/14/22 or the date of Issuer's 2022 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 21:49 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 24,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-21-000048 · edgar.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 302.3567 dividend equivalent rights at $9.42 per RSU credited to the reporting person's account on 07/01/20, 291.5251 dividend equivalent rights at $9.77 per RSU credited to the reporting person's account on 10/07/20, 236.5615 dividend equivalent rights at $12.04 per RSU credited to the reporting person's account on 01/06/21, and 179.1321 dividend equivalent rights at $15.90 per RSU credited to the reporting person's account on 04/07/21. F3 · shares: The number of shares in column 5 includes 1,010 vested RSU dividend equivalent rights and a de minimus adjustment of 0.4246 due to fractional rounding of the dividend equivalent rights at $15.78 per RSU credited to the reporting person's account on 04/14/21. F2 · price: As previously reported, on 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 302.3567 dividend equivalent rights at $9.42 per RSU credited to the reporting person's account on 07/01/20, 291.5251 dividend equivalent rights at $9.77 per RSU credited to the reporting person's account on 10/07/20, 236.5615 dividend equivalent rights at $12.04 per RSU credited to the reporting person's account on 01/06/21, and 179.1321 dividend equivalent rights at $15.90 per RSU credited to the reporting person's account on 04/07/21. F2 · derivative.exercise_date: As previously reported, on 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 302.3567 dividend equivalent rights at $9.42 per RSU credited to the reporting person's account on 07/01/20, 291.5251 dividend equivalent rights at $9.77 per RSU credited to the reporting person's account on 10/07/20, 236.5615 dividend equivalent rights at $12.04 per RSU credited to the reporting person's account on 01/06/21, and 179.1321 dividend equivalent rights at $15.90 per RSU credited to the reporting person's account on 04/07/21. F2 · derivative.expiration_date: As previously reported, on 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which cliff vested on the date of the Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 302.3567 dividend equivalent rights at $9.42 per RSU credited to the reporting person's account on 07/01/20, 291.5251 dividend equivalent rights at $9.77 per RSU credited to the reporting person's account on 10/07/20, 236.5615 dividend equivalent rights at $12.04 per RSU credited to the reporting person's account on 01/06/21, and 179.1321 dividend equivalent rights at $15.90 per RSU credited to the reporting person's account on 04/07/21. Read SEC document |
| April 14, 2021 Filed Apr 15, 2021 21:49 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 24,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001179706-21-000048 · edgar.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 23:37 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000052 · wf-form4_161611066208984.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,742 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of March 17, 2018, in each case subject to the Reporting Person serving as a Director of the Board of the Issuer through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| March 17, 2021 Filed Mar 18, 2021 23:37 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000052 · wf-form4_161611066208984.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:27 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000030 · wf-form4_161472404717515.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358 Underlying: Common Stock · 358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 29, 2020, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 22:27 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-21-000030 · wf-form4_161472404717515.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 22:16 UTC | Sana Biotechnology, Inc. SANA · Entity 4870 | GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005071 · doc4.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-02 F1 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 18, 2021 23:59 UTC Amendment | Sana Biotechnology, Inc. SANA · Entity 4870 | GrantStock Option (Right to Buy) · Derivative | 23,591 | $0.00 Strike: $25.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007193 · doc4a.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,591 Underlying: Common Stock · 23,591 shares Expires 2031-02-02 F1 · shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired. F2 · derivative.exercise_date: The stock option shall vest and become exercisable in full on February 3, 2022. F1 · derivative.underlying_shares: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired. F1 · balance_after: This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 22:13 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 1,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000275 · wf-form4_160832958023977.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,742 Underlying: Common Stock · 1,741 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of March 17, 2018, in each case subject to the Reporting Person serving as a Director of the Board of the Issuer through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 22:13 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 1,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000275 · wf-form4_160832958023977.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 18:10 UTC | COSTCO WHOLESALE CORP /NEW COST · Entity 2803 | GrantCommon Stock | 34 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-062894 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,959 F1 · shares: Represents additional restricted stock units ("RSUs") resulting from the upward adjustment of outstanding unvested RSUs by a factor of 1.019, in connection with the special cash dividend payable by the issuer on December 11, 2020. The adjustment was required under applicable plan documents. The additional RSUs reported are subject to the same vesting schedules as the original unvested RSUs to which they relate. F2 · price: Not applicable. Grant of Restricted Stock Units. Read SEC document |
| November 29, 2020 Filed Dec 1, 2020 01:20 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000244 · wf-form4_160678561859395.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716 Underlying: Common Stock · 358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 29, 2020, in each case subject to the Reporting Person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| November 29, 2020 Filed Dec 1, 2020 01:20 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000244 · wf-form4_160678561859395.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 01:55 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 87 | $39.76 | $3,459.38 |
DisclosureSEC source: 0001209191-20-060410 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,922 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $39.26 to $40.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 01:55 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 35 | $38.65 | $1,352.65 |
DisclosureSEC source: 0001209191-20-060410 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,009 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $38.25 to $39.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 00:06 UTC | COSTCO WHOLESALE CORP /NEW COST · Entity 2803 | GrantCommon Stock | 719 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-055631 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,925 F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2021, and one-third annually on October 22 for the following two years. F2 · price: Not applicable. Grant of Restricted Stock Units. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 22:48 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000221 · wf-form4_160046927087098.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,483 Underlying: Common Stock · 1,742 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of March 17, 2018, in each case subject to the Reporting Person serving as a Director of the Board of the Issuer through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 22:48 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 1,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000221 · wf-form4_160046927087098.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 23:11 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionRestricted Stock Units · Derivative | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000169 · wf-form4_159900187951849.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074 Underlying: Common Stock · 357 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 29, 2020, in each case subject to the reporting person being a service provider through each such date. F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 23:11 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | Exercise / conversionCommon Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000169 · wf-form4_159900187951849.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 23:06 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 41 | $27.55 | $1,129.44 |
DisclosureSEC source: 0001209191-20-048002 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,044 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $27.31 to $27.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 23:06 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 81 | $26.79 | $2,169.79 |
DisclosureSEC source: 0001209191-20-048002 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,085 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $26.28 to $27.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| June 19, 2020 Filed Jun 24, 2020 01:18 UTC | Lyft, Inc. LYFT · Entity 2493 | GrantClass A Common Stock | 7,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038678 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,166 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs shall vest on each of August 20, 2020, November 20, 2020, February 20, 2021, and the earlier of May 20, 2021 or the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date. F2 · balance_after: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 01:09 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | GrantRestricted Stock Units · Derivative | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001261333-20-000096 · wf-form4_159106016487098.xml · derivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,431 Underlying: Common Stock · 1,431 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. F2 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of May 29, 2020, in each case subject to the reporting person being a service provider through each such date. F3 · derivative.expiration_date: The restricted stock units do not expire. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:18 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 189 | $31.45 | $5,943.12 |
DisclosureSEC source: 0001209191-20-031893 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,699 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $31.10 to $31.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:18 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 370 | $30.54 | $11,301.39 |
DisclosureSEC source: 0001209191-20-031893 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,888 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.10 to $31.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| May 01, 2020 Filed May 5, 2020 21:26 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 23,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-20-000073 · edgar.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,735 Underlying: Common Stock · 23,735 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · shares: On 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/21 or the date of Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F3 · price: On 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/21 or the date of Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F3 · derivative.exercise_date: On 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/21 or the date of Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F3 · derivative.expiration_date: On 05/01/20, the reporting person was granted 23,735 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/21 or the date of Issuer's 2021 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 23:13 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 14,443.7978 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179706-20-000046 · edgar.xml · derivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,443.7978 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 103.9282 dividend equivalent rights at $15.29 per RSU credited to the reporting person's account on 07/03/19, 110.0459 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 10/02/19, and 104.8237 dividend equivalent rights at $16.17 per RSU credited to the reporting person's account on 01/02/20. F2 · price: As previously reported, on 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 103.9282 dividend equivalent rights at $15.29 per RSU credited to the reporting person's account on 07/03/19, 110.0459 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 10/02/19, and 104.8237 dividend equivalent rights at $16.17 per RSU credited to the reporting person's account on 01/02/20. F2 · derivative.exercise_date: As previously reported, on 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 103.9282 dividend equivalent rights at $15.29 per RSU credited to the reporting person's account on 07/03/19, 110.0459 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 10/02/19, and 104.8237 dividend equivalent rights at $16.17 per RSU credited to the reporting person's account on 01/02/20. F2 · derivative.expiration_date: As previously reported, on 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 103.9282 dividend equivalent rights at $15.29 per RSU credited to the reporting person's account on 07/03/19, 110.0459 dividend equivalent rights at $14.44 per RSU credited to the reporting person's account on 10/02/19, and 104.8237 dividend equivalent rights at $16.17 per RSU credited to the reporting person's account on 01/02/20. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 23:13 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 14,443.7978 | $0.00 | $0.00 |
DisclosureSEC source: 0001179706-20-000046 · edgar.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,225.7978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 01:37 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 400 | $46.30 | $18,521.40 |
DisclosureSEC source: 0001209191-20-011845 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,258 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $45.79 to $46.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 01:37 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 159 | $45.31 | $7,204.45 |
DisclosureSEC source: 0001209191-20-011845 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,658 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $44.79 to $45.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 01:36 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | GrantCommon Stock | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010843 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,235 F1 · shares: Incentive stock award fully vests on February 14, 2021. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 613 | $53.79 | $32,974.74 |
DisclosureSEC source: 0001209191-20-009000 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,817 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $53.79 to $53.795. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:17 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 1,050 | $51.72 | $54,310.52 |
DisclosureSEC source: 0001209191-20-009000 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,430 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.68 to $51.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 00:57 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 355 | $44.09 | $15,650.25 |
DisclosureSEC source: 0001209191-19-057876 · doc4.xml · nonDerivative · entry 2 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,480 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F4 · price: This transaction was executed in multiple trades at prices ranging from $43.81 to $44.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 00:57 UTC | Lyft, Inc. LYFT · Entity 2493 | SaleClass A Common Stock | 204 | $43.42 | $8,856.93 |
DisclosureSEC source: 0001209191-19-057876 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,835 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $42.81 to $43.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 20:14 UTC | COSTCO WHOLESALE CORP /NEW COST · Entity 2803 | GrantCommon Stock | 901 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-053894 · doc4.xml · nonDerivative · entry 1 Wilderotter Mary Agnes · CIK 0001180610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,206 F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2020, and one-third annually on October 22 for the following two years. F2 · price: Not applicable. Grant of Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.